U.S. Physical Therapy, Inc. (USPH) Stake Cut by Guggenheim Capital LLC


Guggenheim Capital LLC decreased its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 37.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,571 shares of the company’s stock after selling 8,105 shares during the period. Guggenheim Capital LLC owned about 0.11% of U.S. Physical Therapy worth $953,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Sei Investments Co. increased its stake in U.S. Physical Therapy by 115.3% in the third quarter. Sei Investments Co. now owns 1,701 shares of the company’s stock valued at $106,000 after buying an additional 911 shares during the last quarter. Acrospire Investment Management LLC increased its stake in U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock valued at $115,000 after buying an additional 400 shares during the last quarter. Catalyst Capital Advisors LLC bought a new stake in U.S. Physical Therapy during the third quarter valued at about $154,000. Tyers Asset Management LLC bought a new stake in U.S. Physical Therapy during the fourth quarter valued at about $166,000. Finally, Municipal Employees Retirement System of Michigan increased its stake in U.S. Physical Therapy by 1.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 2,770 shares of the company’s stock valued at $174,000 after buying an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company’s stock.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) opened at 63.50 on Wednesday. The firm’s 50-day moving average price is $67.77 and its 200 day moving average price is $66.92. U.S. Physical Therapy, Inc. has a 12-month low of $48.10 and a 12-month high of $78.00. The firm has a market cap of $795.08 million, a P/E ratio of 32.90 and a beta of 0.91.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 5th. Stockholders of record on Monday, April 17th will be paid a $0.20 dividend. The ex-dividend date is Wednesday, April 12th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.17. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.26%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 35.05%.

ILLEGAL ACTIVITY NOTICE: “U.S. Physical Therapy, Inc. (USPH) Stake Cut by Guggenheim Capital LLC” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/04/19/u-s-physical-therapy-inc-usph-stake-cut-by-guggenheim-capital-llc.html.

Several analysts have issued reports on USPH shares. Zacks Investment Research upgraded U.S. Physical Therapy from a “sell” rating to a “buy” rating and set a $79.00 price objective on the stock in a report on Friday, January 6th. Jefferies Group LLC set a $63.00 price objective on U.S. Physical Therapy and gave the stock a “hold” rating in a report on Saturday, March 18th. Finally, Barrington Research downgraded U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, March 17th.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.



Source link

The Citadel Advisors LLC Acquires New Stake in U.S. Physical Therapy, Inc. (USPH)


Citadel Advisors LLC acquired a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 8,461 shares of the company’s stock, valued at approximately $530,000. Citadel Advisors LLC owned approximately 0.07% of U.S. Physical Therapy at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in USPH. Morgan Stanley increased its position in U.S. Physical Therapy by 120.5% in the third quarter. Morgan Stanley now owns 93,266 shares of the company’s stock worth $5,848,000 after buying an additional 50,968 shares during the last quarter. Acrospire Investment Management LLC increased its position in U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock worth $115,000 after buying an additional 400 shares during the last quarter. BRYN MAWR TRUST Co increased its position in U.S. Physical Therapy by 1.1% in the third quarter. BRYN MAWR TRUST Co now owns 28,211 shares of the company’s stock worth $1,769,000 after buying an additional 297 shares during the last quarter. Catalyst Capital Advisors LLC acquired a new position in U.S. Physical Therapy during the third quarter worth approximately $154,000. Finally, King Luther Capital Management Corp increased its position in U.S. Physical Therapy by 2.8% in the third quarter. King Luther Capital Management Corp now owns 36,360 shares of the company’s stock worth $2,280,000 after buying an additional 975 shares during the last quarter. Institutional investors and hedge funds own 97.44% of the company’s stock.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) traded down 0.21% on Wednesday, hitting $70.00. The company’s stock had a trading volume of 58,472 shares. The firm has a market cap of $876.47 million, a PE ratio of 36.27 and a beta of 0.90. The company has a 50 day moving average of $70.33 and a 200 day moving average of $63.84. U.S. Physical Therapy, Inc. has a 1-year low of $45.76 and a 1-year high of $73.05.

A number of research analysts recently issued reports on the company. Zacks Investment Research upgraded U.S. Physical Therapy from a “sell” rating to a “buy” rating and set a $79.00 price target on the stock in a research note on Friday, January 6th. Jefferies Group LLC restated a “hold” rating and set a $63.00 price target (up previously from $60.00) on shares of U.S. Physical Therapy in a research note on Monday, December 5th. JMP Securities restated a “hold” rating on shares of U.S. Physical Therapy in a research note on Monday, November 7th. Finally, Barrington Research upgraded U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $61.00 price target on the stock in a research note on Friday, November 4th.

In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 2,500 shares of the company’s stock in a transaction that occurred on Friday, December 9th. The stock was sold at an average price of $68.40, for a total transaction of $171,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Lawrance W. Mcafee sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $58.04, for a total value of $116,080.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,547 shares of company stock worth $659,654. Insiders own 4.30% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).



Source link